Summary
Johnson & Johnson (JNJ) filed an 8-K on April 14, 2020, to report its first-quarter financial results for the period ended March 29, 2020. The filing primarily consists of a press release and supplementary financial data detailing the company's sales and earnings performance. Investors would be looking to this report for early indications of the company's financial health and operational resilience, especially in the context of the evolving global economic landscape at the time. While the filing itself does not provide the detailed financial figures within the 8-K text, it directs readers to the attached press release (Exhibit 99.1) and supplementary data (Exhibit 99.2) for the specific sales and earnings figures. These exhibits would contain the crucial information regarding revenue, profitability, and any segment-specific performance that investors need to assess JNJ's Q1 2020 results.
Key Highlights
- 1Johnson & Johnson announced its first-quarter 2020 sales and earnings results on April 14, 2020.
- 2The 8-K filing includes a press release (Exhibit 99.1) detailing the Q1 2020 financial performance.
- 3Supplementary financial data, including Unaudited Comparative Supplementary Sales Data and Condensed Consolidated Statement of Earnings, is also provided as Exhibit 99.2.
- 4The report focuses on the financial results for the quarter ended March 29, 2020.
- 5Investors should refer to the attached exhibits for specific financial figures and performance metrics.
- 6This filing serves as the official notification of the company's Q1 2020 financial outcomes.